(Q84846996)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874034%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

A20 edits ubiquitin and autoimmune paradigms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874034%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Flavius Martin

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874034%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Vishva M Dixit

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874034%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

29 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874034%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874034%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874034%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874034%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

822-823

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874034%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ng.916

11 February 2020

exact match

0 references

cites work

The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

1 reference

12 December 2020

A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies

1 reference

12 December 2020

A20: central gatekeeper in inflammation and immunity

1 reference

12 December 2020

B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice

1 reference

12 December 2020

Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis

1 reference

12 December 2020

Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis

1 reference

12 December 2020

The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.

1 reference

12 December 2020

A20: from ubiquitin editing to tumour suppression

1 reference

12 December 2020

A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis.

1 reference

12 December 2020

Targeting lymphocyte co-stimulation: from bench to bedside

1 reference

12 December 2020

Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice

1 reference

12 December 2020

The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology

1 reference

12 December 2020

Rheumatoid arthritis therapy: advances from bench to bedside

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNG.916

7 January 2021

inferred from DOI database lookup

Mouse granzyme K has pro-inflammatory potential.

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNG.916

7 January 2021

inferred from DOI database lookup

The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity.

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNG.916

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NG.916

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21874034%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference